Published in Sci Rep on November 08, 2016
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods (2008) 126.81
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol (2007) 16.46
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
RNA sequencing: advances, challenges and opportunities. Nat Rev Genet (2010) 8.96
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer (1965) 8.54
Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer (2003) 8.06
Mechanisms of cancer drug resistance. Annu Rev Med (2002) 7.91
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
Clonal competition with alternating dominance in multiple myeloma. Blood (2012) 4.39
Genenames.org: the HGNC resources in 2015. Nucleic Acids Res (2014) 3.54
Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res (2005) 3.30
Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta (2008) 2.25
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis (2007) 1.91
Acute myeloid leukaemia in the elderly: a review. Br J Haematol (2011) 1.52
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res (2013) 1.51
High-throughput SNP-based authentication of human cell lines. Int J Cancer (2012) 1.46
NEIL2-initiated, APE-independent repair of oxidized bases in DNA: Evidence for a repair complex in human cells. DNA Repair (Amst) (2006) 1.45
Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer (2007) 1.34
Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol (2014) 1.32
Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. Cancer Chemother Pharmacol (2000) 1.23
A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. J Med Chem (2011) 1.17
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One (2010) 1.16
Glycosphingolipids and drug resistance. Biochim Biophys Acta (2006) 1.13
PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications. Genes Chromosomes Cancer (2011) 1.11
Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci (2015) 1.11
Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res (1990) 1.08
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood (2008) 1.07
Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer (2003) 1.07
Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib. Cell Cycle (2004) 1.04
Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am (2014) 1.04
Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line. Genomics (2012) 1.02
cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J Pharmacol Exp Ther (2001) 0.99
Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling. J Urol (2007) 0.98
Characterization of gene rearrangements leading to activation of MDR-1. J Biol Chem (2006) 0.98
Mouse TEX15 is essential for DNA double-strand break repair and chromosomal synapsis during male meiosis. J Cell Biol (2008) 0.96
Protein kinase Cα protects against multidrug resistance in human colon cancer cells. Mol Cells (2012) 0.95
Targeting vesicle trafficking: an important approach to cancer chemotherapy. Recent Pat Anticancer Drug Discov (2008) 0.95
Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy. Cancer Sci (2015) 0.94
Increased risk of lung cancer associated with a functionally impaired polymorphic variant of the human DNA glycosylase NEIL2. DNA Repair (Amst) (2012) 0.92
The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer. FEBS Lett (2005) 0.92
Involvement of ceramide in cell death responses in the pulmonary circulation. Proc Am Thorac Soc (2011) 0.91
Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia. Am J Hematol (2012) 0.91
Deficiency in DNA mismatch repair increases the rate of telomere shortening in normal human cells. Hum Mutat (2011) 0.91
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget (2015) 0.90
IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines. Cancer Invest (2011) 0.89
Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia. PLoS One (2014) 0.88
Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides. J Exp Ther Oncol (2002) 0.88
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling. Proc Natl Acad Sci U S A (2014) 0.88
The role of P-glycoprotein in drug resistance in multiple myeloma. Leuk Lymphoma (2014) 0.88
Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. BMC Cancer (2013) 0.87
Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers. Oncogene (2001) 0.86
Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia. Leukemia (2015) 0.85
Alternative applications for distinct RNA sequencing strategies. Brief Bioinform (2014) 0.85
PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1. J Exp Clin Cancer Res (2010) 0.85
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells. Cancer Lett (2011) 0.84
Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines. Blood Cells Mol Dis (2002) 0.84
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines. PLoS One (2013) 0.84
Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. Cancer Genomics Proteomics (2010) 0.84
RNA sequencing: from tag-based profiling to resolving complete transcript structure. Cell Mol Life Sci (2014) 0.83
Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines. Cytogenet Genome Res (2002) 0.83
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer. Gynecol Oncol (2014) 0.83
Outcome after failure of second generation tyrosine kinase inhibitors treatment as first-line therapy for patients with chronic myeloid leukemia. Clin Lymphoma Myeloma Leuk (2013) 0.83
Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Autophagy (2015) 0.83
Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15. Cancer Res (2001) 0.83
DNA damage response (DDR) via NKX3.1 expression in prostate cells. J Steroid Biochem Mol Biol (2014) 0.83
Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines. Genes Chromosomes Cancer (2008) 0.83
Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway. Apoptosis (2014) 0.83
Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin. Int J Cancer (2001) 0.82
PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin. Oncogene (2014) 0.82
Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines. Genes Chromosomes Cancer (2005) 0.81
Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia. Oncol Rep (2013) 0.81
Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner. J Biol Chem (2008) 0.80
Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A. Food Chem (2012) 0.80
Modulation of drug resistance in ovarian cancer cells by inhibition of protein kinase C-alpha (PKC-α) with small interference RNA (siRNA) agents. Asian Pac J Cancer Prev (2012) 0.80
Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line. PLoS One (2012) 0.80
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. Cancer Res (2015) 0.79
Implications of NQO1 in cancer therapy. BMB Rep (2015) 0.79
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy. Blood Rev (2015) 0.79
Knockdown of heme oxygenase-1 promotes apoptosis and autophagy and enhances the cytotoxicity of doxorubicin in breast cancer cells. Oncol Lett (2015) 0.79
Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones. Life Sci (2015) 0.79
Genomic imbalances in T-cell acute lymphoblastic leukemia cell lines. Int J Oncol (2002) 0.79
The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagn Pathol (2014) 0.79
Second-line therapy and beyond resistance for the treatment of patients with chronic myeloid leukemia post imatinib failure. Clin Lymphoma Myeloma (2009) 0.79
New paradigms in clonal evolution: punctuated equilibrium in cancer. J Pathol (2016) 0.79
Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells. J Biol Chem (2015) 0.78
Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids. Biochem Pharmacol (2014) 0.78
Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers. Toxins (Basel) (2016) 0.78
Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1. J Cell Biochem (2014) 0.77
Cytogenetic characterization of chromosomal rearrangement in a human vinblastine-resistant CEM cell line: use of comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet Cytogenet (2002) 0.77
Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization. Jpn J Cancer Res (2002) 0.77
Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling. Sci Transl Med (2015) 0.77
Loss of protein kinase Cδ/HuR interaction is necessary to doxorubicin resistance in breast cancer cell lines. J Pharmacol Exp Ther (2014) 0.77
Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients. Pharmacogenomics J (2016) 0.76
Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids. Fundam Clin Pharmacol (2014) 0.76
Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells. PLoS One (2014) 0.76
Balance between exocytosis and endocytosis determines the efficacy of sterol-targeting antibiotics. Chem Biol (2014) 0.76
Loss of chromosome 4 correlates with better long-term survival and lower relapse rate after R0-resection of colorectal liver metastases. J Cancer Res Clin Oncol (2013) 0.75
Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells. Oncotarget (2015) 0.86
Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib. Int J Cancer (2015) 0.81
X-linked intellectual disability related genes disrupted by balanced X-autosome translocations. Am J Med Genet B Neuropsychiatr Genet (2015) 0.80
The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget (2016) 0.79
Mechanism of action of Rhodiola, salidroside, tyrosol and triandrin in isolated neuroglial cells: an interactive pathway analysis of the downstream effects using RNA microarray data. Phytomedicine (2014) 0.79
MLLT10 and IL3 rearrangement together with a complex four-way translocation and trisomy 4 in a patient with early T-cell precursor acute lymphoblastic leukemia: A case report. Oncol Rep (2014) 0.79
Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine (2014) 0.79
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking. J Nutr Biochem (2014) 0.79
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses. Biochem Pharmacol (2016) 0.78
Posttraumatic stress disorder among earthquake survivors of the Wenchuan area (Sichuan, China). Eur J Psychotraumatol (2014) 0.78
Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua. Nat Prod Bioprospect (2014) 0.77
The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65. Antiviral Res (2015) 0.76
Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells. Phytomedicine (2014) 0.76
Novel sequential stress model for functional dyspepsia: Efficacy of the herbal preparation STW5. Phytomedicine (2015) 0.76
Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals. Target Oncol (2014) 0.76
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2). Breast Cancer Res Treat (2017) 0.75
Alpha-fetoprotein and its value for predicting pregnancy outcomes - a re-evaluation. J Prenat Med (2016) 0.75
European registration process for Clinical Laboratory Geneticists in genetic healthcare. Eur J Hum Genet (2017) 0.75
High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia. Mol Cytogenet (2015) 0.75
A New Case of a Complex Small Supernumerary Marker Chromosome: A Der(9)t(7;9)(p22;q22) due to a Maternal Balanced Rearrangement. J Pediatr Genet (2015) 0.75
Thorough discussion of cancer research-thoughts against the main stream. Eur J Hum Genet (2017) 0.75
Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1. Anticancer Res (2015) 0.75
Next generation phenotyping in Emanuel and Pallister Killian Syndrome using computer-aided facial dysmorphology analysis of 2D photos. Clin Genet (2017) 0.75
A Five-year Survey of Cancer Prevalence in Sudan. Anticancer Res (2016) 0.75
Substituted steroidal compounds containing amino and amido groups reverse multidrug resistance of mouse T-lymphoma and two human prostate cancer cell lines in vitro. Anticancer Res (2015) 0.75
Unusual de novo Partial Trisomy 17p12p11.2 due to Unbalanced Insertion into 5p13.1 in a Severely Affected Boy. J Pediatr Genet (2017) 0.75
Kaempferol Is an Anti-Inflammatory Compound with Activity towards NF-κB Pathway Proteins. Anticancer Res (2015) 0.75
Introduction: Novel hybrid combinations containing synthetic or antibiotic drugs with plant-derived phenolic or terpenoid compounds. Phytomedicine (2017) 0.75
Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget (2017) 0.75
Evaluation of Long-Time Decoction-Detoxicated (Processed Debeaux Lateral Root With Peel) for Its Acute Toxicity and Therapeutic Effect on Mono-Iodoacetate Induced Osteoarthritis. Front Pharmacol (2020) 0.75
How to Obtain High-Quality Metaphase Spreads for Molecular Cytogenetics. Curr Protoc (2022) 0.75
Synergy assessment of fixed combinations of Herba Andrographidis and Radix Eleutherococci extracts by transcriptome-wide microarray profiling. Phytomedicine (2015) 0.75
Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-κB activity. Oncotarget (2017) 0.75